{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:03:12Z","timestamp":1779922992922,"version":"3.53.1"},"reference-count":40,"publisher":"Pleiades Publishing Ltd","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochemistry Moscow"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>\n                      Cytokines play a critical role in brain functioning by modulating neurotransmitter and energy metabolism, neuroplasticity, and neuronal activity. Dysregulated or excessive cytokine production can disrupt neuronal metabolic processes and contribute to brain dysfunction. Among the proposed mechanisms underlying the development and progression of affective disorders (ADs), the cytokine hypothesis emphasizes the role of inflammatory markers as key factors in the development of depressive pathologies. The aim of this study was to investigate molecular characteristics of selected immunoinflammatory markers in patients with\u00a0AD. The study included 239 patients diagnosed with AD and 205 healthy controls. Polymorphic variants of the immunoinflammatory genes\n                      <jats:italic>IL1B<\/jats:italic>\n                      (\n                      <jats:italic>rs16944<\/jats:italic>\n                      ,\n                      <jats:italic>rs1143627<\/jats:italic>\n                      ),\n                      <jats:italic>IL13<\/jats:italic>\n                      (\n                      <jats:italic>rs1295686<\/jats:italic>\n                      ),\n                      <jats:italic>TNFB<\/jats:italic>\n                      (\n                      <jats:italic>rs2229094<\/jats:italic>\n                      ), and\n                      <jats:italic>TGFA<\/jats:italic>\n                      (\n                      <jats:italic>rs2166975<\/jats:italic>\n                      ) were analyzed, and cytokine levels in the blood serum and peripheral blood mononuclear cells were measured. As\u00a0association was identified between the\n                      <jats:italic>rs2229094<\/jats:italic>\n                      polymorphism of the\n                      <jats:italic>TNFB<\/jats:italic>\n                      gene and\u00a0AD: the carriage of the\n                      <jats:italic>A<\/jats:italic>\n                      \u00a0allele and the\n                      <jats:italic>AA<\/jats:italic>\n                      \u00a0genotype of this variant was associated with an increased risk of\u00a0AD. Furthermore, the levels of TGF-\u03b1 and IL-13 in peripheral blood mononuclear cells and the serum content of TNF-\u03b2 were significantly elevated in patients with AD compared with healthy controls. These pilot findings suggest that the studied cytokines may contribute to the pathogenetic mechanisms underlying development of ADs.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1134\/s0006297926600304","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T22:14:56Z","timestamp":1779920096000},"page":"780-788","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunoinflammatory Markers in Patients with Affective Disorders: Genetic Polymorphisms, Peripheral Cytokine Levels, and Expression of IL-1\u03b2, IL-13, TNF-\u03b2, and TGF-\u03b1 in Peripheral Blood Mononuclear Cells"],"prefix":"10.1134","volume":"91","author":[{"given":"Ekaterina V.","family":"Mikhalitskaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyudmila A.","family":"Levchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia S.","family":"Boiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalya M.","family":"Vyalova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena V.","family":"Epimakhova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Z.","family":"Paderina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga V.","family":"Roschina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German G.","family":"Simutkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay A.","family":"Bokhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana A.","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"137","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"3037_CR1","doi-asserted-by":"publisher","DOI":"10.5498\/wjp.v6.i3.283","volume":"6","author":"S. W. Jeon","year":"2016","unstructured":"Jeon, S. W., and Kim, Y. K. (2016) Neuroinflammation and cytokine abnormality in major depression: cause or consequence in that illness? World\u00a0J. Psychiatry, 6, 283, \nhttps:\/\/doi.org\/10.5498\/wjp.v6.i3.283.","journal-title":"World\u00a0J. Psychiatry"},{"key":"3037_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.26617\/1810-3111-2018-2(99)-45-55","volume":"2","author":"V. B. Nikitina","year":"2018","unstructured":"Nikitina, V. B., Lobacheva, O. A., Vetlugina, T. P., Aksyonov, M. M., and Lebedeva, V. F. (2018) Neuroimmune-endocrine disorders in mental disorders and addiction diseases, Sib.\u00a0J. Psychiatry Narcol., 2, 45-55, \nhttps:\/\/doi.org\/10.26617\/1810-3111-2018-2(99)-45-55.","journal-title":"Sib.\u00a0J. Psychiatry Narcol."},{"key":"3037_CR3","doi-asserted-by":"publisher","first-page":"C205","DOI":"10.1152\/ajpcell.00246.2024","volume":"327","author":"J. Steffen","year":"2024","unstructured":"Steffen, J., Focken, N., and \u00c7al\u0131\u015fkan, G. (2024) Recognizing depression as an inflammatory disease: the search for endotypes, Am.\u00a0J. Physiol. Cell Physiol., 327, C205-C212, \nhttps:\/\/doi.org\/10.1152\/ajpcell.00246.2024.","journal-title":"Am.\u00a0J. Physiol. Cell Physiol."},{"key":"3037_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/ejn.14720","volume":"53","author":"R. Troubat","year":"2021","unstructured":"Troubat, R., Barone, P., Leman, S., Desmidt, T., Cressant, A., Atanasova, B., Brizard, B., El Hage, W., Surget, A., Belzung, C., and Camus, V. (2021) Neuroinflammation and depression: a review, Eur.\u00a0J. Neurosci., 53, 151-171, \nhttps:\/\/doi.org\/10.1111\/ejn.14720.","journal-title":"Eur.\u00a0J. Neurosci."},{"key":"3037_CR5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1136\/jnnp-2011-301779","volume":"83","author":"R. Krishnadas","year":"2012","unstructured":"Krishnadas, R., and Cavanagh, J. (2012) Depression: an inflammatory illness? J.\u00a0Neurol. Neurosurg. Psychiatry, 83, 495-502, \nhttps:\/\/doi.org\/10.1136\/jnnp-2011-301779.","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"3037_CR6","volume":"180","author":"L. Fisker","year":"2018","unstructured":"Fisker, L., K\u00f6hler-Forsberg, O., and Hageman, I. (2018) The\u00a0relation between depression and inflammation, Ugeskr Laeger, 180, V09170675.","journal-title":"Ugeskr Laeger"},{"key":"3037_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1646740","volume":"16","author":"Y. Zheng","year":"2025","unstructured":"Zheng, Y., and Xu, L. (2025) Bidirectional crosstalk between microglia and serotonin signaling in neuroinflammation and CNS disorders, Front. Immunol., 16, 1646740, \nhttps:\/\/doi.org\/10.3389\/fimmu.2025.1646740.","journal-title":"Front. Immunol."},{"key":"3037_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-51932-9","volume":"14","author":"N. Sarmin","year":"2024","unstructured":"Sarmin, N., Roknuzzaman, A. S. M., Mouree, T. Z., Islam, M. R., and Al Mahmud, Z. (2024) Evaluation of serum interleukin-12 and interleukin-4 as potential biomarkers for the diagnosis of major depressive disorder, Sci. Rep., 14, 1652, \nhttps:\/\/doi.org\/10.1038\/s41598-024-51932-9.","journal-title":"Sci. Rep."},{"key":"3037_CR9","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.bbi.2020.02.010","volume":"87","author":"E. F. Osimo","year":"2020","unstructured":"Osimo, E. F., Pillinger, T., Rodriguez, I. M., Khandaker, G. M., Pariante, C. M., and Howes, O. D. (2020) Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5,166\u00a0patients and 5,083\u00a0controls, Brain Behav. Immunity, 87, 901-909, \nhttps:\/\/doi.org\/10.1016\/j.bbi.2020.02.010.","journal-title":"Brain Behav. Immunity"},{"key":"3037_CR10","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41573-021-00368-1","volume":"21","author":"W. C. Drevets","year":"2022","unstructured":"Drevets, W. C., Wittenberg, G. M., Bullmore, E. T., and Manji, H. K. (2022) Immune targets for therapeutic development in depression: towards precision medicine, Nat. Rev. Drug Discov., 21, 224-244, \nhttps:\/\/doi.org\/10.1038\/s41573-021-00368-1.","journal-title":"Nat. Rev. Drug Discov."},{"key":"3037_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.935031","volume":"15","author":"Y. Li","year":"2022","unstructured":"Li, Y., Yue, Y., Chen, S., Jiang, W., Xu, Z., Chen, G., Zhu, Z., Tan, L., and Yuan, Y. (2022) Combined serum IL-6, C-reactive protein, and cortisol may distinguish patients with anhedonia in major depressive disorder, Front. Mol. Neurosci., 15, 935031, \nhttps:\/\/doi.org\/10.3389\/fnmol.2022.935031.","journal-title":"Front. Mol. Neurosci."},{"key":"3037_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/15622975.2022.2095439","volume":"24","author":"I. A. Mednova","year":"2023","unstructured":"Mednova, I. A., Levchuk, L. A., Boiko, A.\u00a0S., Roschina, O. V., Simutkin, G.\u00a0G., Bokhan, N. A., Loonen, A. J. M., and Ivanova, S.\u00a0A. (2023) Cytokine level in patients with mood disorder, alcohol use disorder and their comorbidity, World\u00a0J. Biol. Psychiatry, 24, 243-253, \nhttps:\/\/doi.org\/10.1080\/15622975.2022.2095439.","journal-title":"World\u00a0J. Biol. Psychiatry"},{"key":"3037_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.5498\/wjp.v12.i1.77","volume":"12","author":"G. A. Porter","year":"2022","unstructured":"Porter, G. A., and O\u2019Connor, J. C. (2022) Brain-derived neurotrophic factor and inflammation in depression: pathogenic partners in crime? World\u00a0J. Psychiatry, 12, 77-97, \nhttps:\/\/doi.org\/10.5498\/wjp.v12.i1.77.","journal-title":"World\u00a0J. Psychiatry"},{"key":"3037_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cells13050423","volume":"13","author":"B. R. Kouba","year":"2024","unstructured":"Kouba, B. R., de Araujo Borba, L., Borges de Souza, P., Gil-Mohapel, J., and Rodrigues, A. L. S. (2024) Role of inflammatory mechanisms in major depressive disorder: from etiology to potential pharmacological targets, Cells, 13, 423, \nhttps:\/\/doi.org\/10.3390\/cells13050423.","journal-title":"Cells"},{"key":"3037_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2025.107656","volume":"183","author":"X. Shen","year":"2026","unstructured":"Shen, X., Ji, W., Zheng, H., Yu, B., Wan, Y., Cai, H., Dai, H., and Zhong, H. (2026) Peripheral cytokine dysregulation, microglial dysfunction in adolescent major depressive disorder: neuroimmune crosstalk implications, Psychoneuroendocrinology, 183, 107656, \nhttps:\/\/doi.org\/10.1016\/j.psyneuen.2025.107656.","journal-title":"Psychoneuroendocrinology"},{"key":"3037_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-025-03643-6","volume":"15","author":"W. Li","year":"2025","unstructured":"Li, W., You, Z., Wang, C., Lan, X., Zhang, F., Hu, Z., Chen, X., Luo, Z., Zeng, Y., Chen, Y., Chen, Y., Mai, S., Shao, R., Lu, H., McIntyre, R.\u00a0S., Sun, X., Ning, Y., and Zhou, Y. (2025) White matter free water and depressive symptoms in medication-free depressed adolescents: moderation by peripheral inflammation, Translat. Psychiatry, 15, 407, \nhttps:\/\/doi.org\/10.1038\/s41398-025-03643-6.","journal-title":"Translat. Psychiatry"},{"key":"3037_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.yexmp.2018.08.002","volume":"105","author":"D. V. Chistyakov","year":"2018","unstructured":"Chistyakov, D. V., Astakhova, A. A., and Sergeeva, M. G. (2018) Resolution of inflammation and mood disorders, Exp. Mol. Pathol., 105, 190-201, \nhttps:\/\/doi.org\/10.1016\/j.yexmp.2018.08.002.","journal-title":"Exp. Mol. Pathol."},{"key":"3037_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jad.2025.02.040","volume":"377","author":"X. Liu","year":"2025","unstructured":"Liu, X., Li, Y., Yang, W., Chen, X., Li, F., Chen, N., Yin, H., and Cui, J. (2025) Blood lipid profiles and mood disorders: a principal component analysis of UK biobank data reveals distinct associations with depression and bipolar disorder, J.\u00a0Affect. Disord., 377, 23-34, \nhttps:\/\/doi.org\/10.1016\/j.jad.2025.02.040.","journal-title":"J.\u00a0Affect. Disord."},{"key":"3037_CR19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.pnpbp.2004.01.009","volume":"28","author":"A. Gladkevich","year":"2004","unstructured":"Gladkevich, A., Kauffman, H. F., and Korf, J. (2004) Lymphocytes as a neural probe: potential for studying psychiatric disorders, Progr. Neuro Psychopharmacol. Biol. Psychiatry, 28, 559-576, \nhttps:\/\/doi.org\/10.1016\/j.pnpbp.2004.01.009.","journal-title":"Progr. Neuro Psychopharmacol. Biol. Psychiatry"},{"key":"3037_CR20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.20538\/1682-0363-2019-1-84-95","volume":"18","author":"A. S. Simbirtsev","year":"2019","unstructured":"Simbirtsev, A. S. (2019) Immunopharmacological aspects of the cytokine system, Bull. Sib Med., 18, 84-95, \nhttps:\/\/doi.org\/10.20538\/1682-0363-2019-1-84-95.","journal-title":"Bull. Sib Med."},{"key":"3037_CR21","first-page":"200","volume":"2","author":"A. Sh. Oradova","year":"2017","unstructured":"Oradova, A. Sh., Saduakasova, K. Z., and Lesova, S. D. (2017) Laboratory diagnostics of cytokines (review article), Bull. Kazakh Natl. Med. Univ., 2, 200-203.","journal-title":"Bull. Kazakh Natl. Med. Univ."},{"key":"3037_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2025.116492","volume":"348","author":"M. Oraki Kohshour","year":"2025","unstructured":"Oraki Kohshour, M., Adorjan, K., Budde, M., Heilbronner, M., Kalman, J.\u00a0L., Navarro-Flores, A., Reich-Erkelenz, D., Schulte, E.\u00a0C., Senner, F., Vogl, T., Anghelescu, I.-G., Arolt, V., Baune, B.\u00a0T., Dannlowski, U., Dietrich, D.\u00a0E., Fallgatter, A.\u00a0J., Figge, C., Lang, F.\u00a0U., Juckel, G., Konrad, C., Reimer, J., Reininghaus, E.\u00a0Z., Schmau\u00df, M., Schmitt, A., Spitzer, C., Wiltfang, J., Zimmermann, J., Falkai, P., Heilbronner, U., Papiol, S., and Schulze, T.\u00a0G. (2025) How variants in inflammatory mediator genes influence symptom severity of psychiatric disorders: findings from the PsyCourse study, Psychiatry Res., 348, 116492, \nhttps:\/\/doi.org\/10.1016\/j.psychres.2025.116492.","journal-title":"Psychiatry Res."},{"key":"3037_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/genes14071460","volume":"14","author":"E. V. Mikhalitskaya","year":"2023","unstructured":"Mikhalitskaya, E. V., Vyalova, N.\u00a0M., Ermakov, E.\u00a0A., Levchuk, L.\u00a0A., Simutkin, G.\u00a0G., Bokhan, N.\u00a0A., and Ivanova, S.\u00a0A. (2023) Association of single nucleotide polymorphisms of cytokine genes with depression, schizophrenia and bipolar disorder, Genes, 14, 1460, \nhttps:\/\/doi.org\/10.3390\/genes14071460.","journal-title":"Genes"},{"key":"3037_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.46235\/1028-7221-17220-PVO","volume":"29","author":"L. A. Levchuk","year":"2026","unstructured":"Levchuk, L. A., Vyalova, N.\u00a0M., Mikhalitskaya, E. V., Paderina, D.\u00a0Z., Roschina, O. V., Simutkin, G.\u00a0G., Bokhan, N.\u00a0A., and Ivanova, S.\u00a0A. (2026) Polymorphic variants of proinflammatory cytokine genes in affective disorders and in cases of comorbidity with alcohol addiction, Russ.\u00a0J. Immunol., 29, 131-142, \nhttps:\/\/doi.org\/10.46235\/1028-7221-17220-PVO.","journal-title":"Russ.\u00a0J. Immunol."},{"key":"3037_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1146\/annurev-immunol-020711-075015","volume":"30","author":"U. Andersson","year":"2012","unstructured":"Andersson, U., and Tracey, K. J. (2012) Reflex principles of immunological homeostasis, Annu. Rev. Immunol., 30, 313-335, \nhttps:\/\/doi.org\/10.1146\/annurev-immunol-020711-075015.","journal-title":"Annu. Rev. Immunol."},{"key":"3037_CR26","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/164_2018_166","volume":"250","author":"J. C. Felger","year":"2018","unstructured":"Felger, J. C. (2018) Role of inflammation in depression and treatment implications, Handb. Exp. Pharmacol., 250, 255-286, \nhttps:\/\/doi.org\/10.1007\/164_2018_166.","journal-title":"Handb. Exp. Pharmacol."},{"key":"3037_CR27","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.psyneuen.2012.05.008","volume":"37","author":"F. S. Dhabhar","year":"2012","unstructured":"Dhabhar, F. S., Malarkey, W. B., Neri, E., and McEwen, B. S. (2012) Stress-induced redistribution of immune cells\u00a0\u2013 from barracks to boulevards to battlefields: a tale of three hormones\u00a0\u2013 Curt Richter Award winner, Psychoneuroendocrinology, 37, 1345-1368, \nhttps:\/\/doi.org\/10.1016\/j.psyneuen.2012.05.008.","journal-title":"Psychoneuroendocrinology"},{"key":"3037_CR28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41684-021-00884-y","volume":"50","author":"A. Le Bras","year":"2021","unstructured":"Le Bras, A. (2021) Chronic stress and inflammation, Lab Anim. (NY), 50, 309-309, \nhttps:\/\/doi.org\/10.1038\/s41684-021-00884-y.","journal-title":"Lab Anim. (NY)"},{"key":"3037_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-023-00454-1","volume":"9","author":"W. Marx","year":"2023","unstructured":"Marx, W., Penninx, B. W. J. H., Solmi, M., Furukawa, T.\u00a0A., Firth, J., Carvalho, A.\u00a0F., and Berk, M. (2023) Major depressive disorder, Nat. Rev. Dis. Primers, 9, 44, \nhttps:\/\/doi.org\/10.1038\/s41572-023-00454-1.","journal-title":"Nat. Rev. Dis. Primers"},{"key":"3037_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010578","volume":"24","author":"S. Harsanyi","year":"2022","unstructured":"Harsanyi, S., Kupcova, I., Danisovic, L., and Klein, M. (2022) Selected biomarkers of depression: what are the effects of cytokines and inflammation? Int.\u00a0J. Mol. Sci., 24, 578, \nhttps:\/\/doi.org\/10.3390\/ijms24010578.","journal-title":"Int.\u00a0J. Mol. Sci."},{"key":"3037_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30487-6","volume":"8","author":"A. Ng","year":"2018","unstructured":"Ng, A., Tam, W. W., Zhang, M.\u00a0W., Ho, C.\u00a0S., Husain, S.\u00a0F., McIntyre, R.\u00a0S., and Ho, R.\u00a0C. (2018) IL-1\u03b2, IL-6, TNF-\u03b1 and CRP in elderly patients with depression or Alzheimer\u2019s disease: systematic review and meta-analysis, Sci. Rep., 8, 12050, \nhttps:\/\/doi.org\/10.1038\/s41598-018-30487-6.","journal-title":"Sci. Rep."},{"key":"3037_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2024.111951","volume":"187","author":"M. Maes","year":"2024","unstructured":"Maes, M., Jirakran, K., Vasupanrajit, A., Zhou, B., Tunvirachaisakul, C., and Almulla, A.\u00a0F. (2024) Major depressive disorder, neuroticism, suicidal behaviors, and depression severity are associated with cytokine networks and their intricate interactions with metabolic syndrome, J.\u00a0Psychosomatic Res., 187, 111951, \nhttps:\/\/doi.org\/10.1016\/j.jpsychores.2024.111951.","journal-title":"J.\u00a0Psychosomatic Res."},{"key":"3037_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.102982","volume":"52","author":"A. M. Ferreira","year":"2021","unstructured":"Ferreira, A. M., Leal, B., Ferreira, I., Br\u00e1s, S., Moreira, I., Sam\u00f5es, R., Sousa, A. P., Santos, E., Silva, B., Costa, P. P., Cavaco, S., and Martins da Silva, A. (2021) Depression and anxiety in multiple sclerosis patients: the role of genetic variability of interleukin\u00a01\u03b2, Multiple Scleros. Relat. Disord., 52, 102982, \nhttps:\/\/doi.org\/10.1016\/j.msard.2021.102982.","journal-title":"Multiple Scleros. Relat. Disord."},{"key":"3037_CR34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/1099800414550394","volume":"17","author":"S.-H. Doong","year":"2015","unstructured":"Doong, S.-H., Dhruva, A., Dunn, L.\u00a0B., West, C., Paul, S.\u00a0M., Cooper, B.\u00a0A., Elboim, C., Abrams, G., Merriman, J.\u00a0D., Langford, D.\u00a0J., Leutwyler, H., Baggott, C., Kober, K., Aouizerat, B.\u00a0E., and Miaskowski, C. (2015) Associations between cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression in patients prior to breast cancer surgery, Biol. Res. Nurs., 17, 237-247, \nhttps:\/\/doi.org\/10.1177\/1099800414550394.","journal-title":"Biol. Res. Nurs."},{"key":"3037_CR35","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jneuroim.2005.08.014","volume":"172","author":"L. Pav\u00f3n","year":"2006","unstructured":"Pav\u00f3n, L., Sandoval-L\u00f3pez, G., Hern\u00e1ndez, M. E., Lor\u00eda, F., Estrada, I., P\u00e9rez, M., Moreno, J., \u00c1vila, U., Leff, P., Ant\u00f3n, B., and Heinze, G. (2006) Th2\u00a0cytokine response in major depressive disorder patients before treatment, J.\u00a0Neuroimmunol., 172, 156-165, \nhttps:\/\/doi.org\/10.1016\/j.jneuroim.2005.08.014.","journal-title":"J.\u00a0Neuroimmunol."},{"key":"3037_CR36","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/S1734-1140(13)71517-2","volume":"65","author":"M. Siwek","year":"2013","unstructured":"Siwek, M., Sowa-Ku\u0107ma, M., Dudek, D., Stycze\u0144, K., Szewczyk, B., Kotarska, K., Misztak, P., Pilc, A., Wolak, M., and Nowak, G. (2013) Oxidative stress markers in affective disorders, Pharmacol. Rep., 65, 1558-1571, \nhttps:\/\/doi.org\/10.1016\/S1734-1140(13)71517-2.","journal-title":"Pharmacol. Rep."},{"key":"3037_CR37","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ejon.2012.10.004","volume":"17","author":"L.\u00a0B. Dunn","year":"2013","unstructured":"Dunn, L.\u00a0B., Aouizerat, B.\u00a0E., Langford, D.\u00a0J., Cooper, B.\u00a0A., Dhruva, A., Cataldo, J.\u00a0K., Baggott, C.\u00a0R., Merriman, J.\u00a0D., Dodd, M., West, C., Paul, S.\u00a0M., and Miaskowski, C. (2013) Cytokine gene variation is associated with depressive symptom trajectories in oncology patients and family caregivers, Eur.\u00a0J. Oncol. Nurs., 17, 346-353, \nhttps:\/\/doi.org\/10.1016\/j.ejon.2012.10.004.","journal-title":"Eur.\u00a0J. Oncol. Nurs."},{"key":"3037_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2020.113568","volume":"295","author":"R. Das","year":"2021","unstructured":"Das, R., Emon, M. P. Z., Shahriar, M., Nahar, Z., Islam, S.\u00a0M.\u00a0A., Bhuiyan, M.\u00a0A., Islam, S.\u00a0N., and Islam, M.\u00a0R. (2021) Higher levels of serum IL-1\u03b2 and TNF-\u03b1 are associated with an increased probability of major depressive disorder, Psychiatry Res., 295, 113568, \nhttps:\/\/doi.org\/10.1016\/j.psychres.2020.113568.","journal-title":"Psychiatry Res."},{"key":"3037_CR39","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.8676","volume":"8","author":"K. Bialek","year":"2020","unstructured":"Bialek, K., Czarny, P., Watala, C., Wigner, P., Talarowska, M., Galecki, P., Szemraj, J., and Sliwinski, T. (2020) Novel association between TGFA, TGFB1, IRF1, PTGS2 and IKBKB single-nucleotide polymorphisms and occurrence, severity and treatment response of major depressive disorder, PeerJ, 8, e8676, \nhttps:\/\/doi.org\/10.7717\/peerj.8676.","journal-title":"PeerJ"},{"key":"3037_CR40","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40291-021-00516-8","volume":"25","author":"J. Goossens","year":"2021","unstructured":"Goossens, J., Morrens, M., and Coppens, V. (2021) The\u00a0potential use of peripheral blood mononuclear cells as biomarkers for treatment response and outcome prediction in psychiatry: a systematic review, Mol. Diagn. Ther., 25, 283-299, \nhttps:\/\/doi.org\/10.1007\/s40291-021-00516-8.","journal-title":"Mol. Diagn. Ther."}],"container-title":["Biochemistry (Moscow)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297926600304.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S0006297926600304","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297926600304.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T22:14:57Z","timestamp":1779920097000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S0006297926600304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["3037"],"URL":"https:\/\/doi.org\/10.1134\/s0006297926600304","relation":{},"ISSN":["0006-2979","1608-3040"],"issn-type":[{"value":"0006-2979","type":"print"},{"value":"1608-3040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and consent to participate.\n                      The study was conducted in accordance with the ethical principles of human research and was approved by the Biomedical Ethics Committee of the Mental Health Research Institute, Tomsk National Research Medical Center, and was in compliance with the Helsinki Declaration for experiments involving humans (protocol no.\u00a0164 from June\u00a016,\u00a02023). All patients signed informed consent to participate in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"Conflict of interest.\n                      The authors of this work declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}]}}